Interaction between Antibody-Diversification Enzyme AID and Spliceosome-Associated Factor CTNNBL1

Molecular Cell

Volumn 31, Issue 4, 2008, Pages 474-484

  Conticello, Silvestro G ^a   Ganesh, Karuna ^a   Xue, Kanmin ^a   Lu, Mason ^a   Rada, Cristina ^a   Neuberger, Michael S ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

DNA; MOLIMMUNO; RNA

Indexed keywords

DEAMINASE; NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SPLICEOSOME;

ANIMALS; ANTIBODY DIVERSITY; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; CHICKENS; CYTIDINE DEAMINASE; HUMANS; MUTANT PROTEINS; MUTATION; NUCLEAR PROTEINS; PROTEIN BINDING; RATS; RNA-BINDING PROTEINS; SPLICEOSOMES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 49349112190     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.07.009     Document Type: Article

References (39)

1. Aguilera A. mRNA processing and genomic instability. Nat. Struct. Mol. Biol. 12 (2005) 737-738
2. In: Alt F.W., and Honjo T. (Eds). AID for Immunoglobulin Diversity (2007), Elsevier Academic Press, Amsterdam
3. Arakawa H., Hauschild J., and Buerstedde J.M. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295 (2002) 1301-1306
4. Arakawa H., Saribasak H., and Buerstedde J.M. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol. 2 (2004) E179
5. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., Schrum J.P., Manis J.P., and Alt F.W. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438 (2005) 508-511
6. Beck B.D., Park S.-J., Lee Y.-J., Roman Y., Hromas R.A., and Lee S.-H. Human Pso4 is a metnase (SETMAR)-binding partner that regulates metnase function in DNA repair. J. Biol. Chem. 283 (2008) 9023-9030
7. Brar S.S., Watson M., and Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279 (2004) 26395-26401
8. Broder Y.C., Katz S., and Aronheim A. The ras recruitment system, a novel approach to the study of protein-protein interactions. Curr. Biol. 8 (1998) 1121-1124
9. Buerstedde J.M., Reynaud C.A., Humphries E.H., Olson W., Ewert D.L., and Weill J.C. Light chain gene conversion continues at high rate in an ALV-induced cell line. EMBO J. 9 (1990) 921-927
10. Coates J.C. Armadillo repeat proteins: beyond the animal kingdom. Trends Cell Biol. 13 (2003) 463-471
11. Damgaard C.K., Kahns S., Lykke-Andersen S., Nielsen A.L., Jensen T.H., and Kjems J. A 5′ splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol. Cell 29 (2008) 271-278
12. Di Noia J.M., and Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76 (2007) 1-22
13. Görnemann J., Kotovic K.M., Huja K., and Neugebauer K.M. Cotranscriptional spliceosome assembly occurs in a stepwise fashion and requires the cap binding complex. Mol. Cell 19 (2005) 53-63
14. Harris R.S., Sale J.E., Petersen-Mahrt S.K., and Neuberger M.S. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12 (2002) 435-438
15. Hein K., Lorenz M.G., Siebenkotten G., Petry K., Christine R., and Radbruch A. Processing of switch transcripts is required for targeting of antibody class switch recombination. J. Exp. Med. 188 (1998) 2369-2374
16. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., and Honjo T. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101 (2004) 1975-1980
17. Jabbour L., Welter J.F., Kollar J., and Hering T.M. Sequence, gene structure, and expression pattern of CTNNBL1, a minor-class intron-containing gene-evidence for a role in apoptosis. Genomics 81 (2003) 292-303
18. Kornblihtt A.R., de la Mata M., Fededa J.P., Munoz M.J., and Nogues G. Multiple links between transcription and splicing. RNA 10 (2004) 1489-1498
19. Kotovic K.M., Lockshon D., Boric L., and Neugebauer K.M. Cotranscriptional recruitment of the U1 snRNP to intron-containing genes in yeast. Mol. Cell. Biol. 23 (2003) 5768-5779
20. Langlois M.A., Beale R.C., Conticello S.G., and Neuberger M.S. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res. 33 (2005) 1913-1923
21. Li X., and Manley J.L. Cotranscriptional processes and their influence on genome stability. Genes Dev. 20 (2006) 1838-1847
22. Longerich S., Basu U., Alt F., and Storb U. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18 (2006) 164-174
23. Lu X., and Legerski R.J. The Prp19/Pso4 core complex undergoes ubiquitylation and structural alterations in response to DNA damage. Biochem. Biophys. Res. Commun. 354 (2007) 968-974
24. Makarova O.V., Makarov E.M., Urlaub H., Will C.L., Gentzel M., Wilm M., and Lührmann R. A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing. EMBO J. 23 (2004) 2381-2391
25. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P., and Nussenzweig M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199 (2004) 1235-1244
26. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., and Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103 (2006) 8798-8803
27. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 (2000) 1063-1066
28. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
29. Odegard V.H., and Schatz D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 6 (2006) 573-583
30. Pasqualucci L., Guglielmino R., Houldsworth J., Mohr J., Aoufouchi S., Polakiewicz R., Chaganti R.S., and Dalla-Favera R. Expression of the AID protein in normal and neoplastic B cells. Blood 104 (2004) 3318-3325
31. Pasqualucci L., Kitaura Y., Gu H., and Dalla-Favera R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103 (2006) 395-400
32. Petersen-Mahrt S.K., and Neuberger M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 278 (2003) 19583-19586
33. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
34. Rada C., Jarvis J.M., and Milstein C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 99 (2002) 7003-7008
35. Randow F., and Sale J.E. Retroviral transduction of DT40. Subcell. Biochem. 40 (2006) 383-386
36. Sadowski I. Plasmids for one- and two-hybrid analysis in mammalian cells. Anal. Biochem. 256 (1998) 245-247
37. Sale J.E., Calandrini D.M., Takata M., Takeda S., and Neuberger M.S. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412 (2001) 921-996
38. Sims III R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., Manley J.L., and Reinberg D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28 (2007) 665-676
39. Zhu Y., Nonoyama S., Morio T., Muramatsu M., Honjo T., and Mizutani S. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J. Med. Dent. Sci. 50 (2003) 41-46